Autres langues Cisen Pharmaceutical Co., Ltd.

Actions

603367

CNE100002VG4

Cours en clôture Shanghai S.E. Autres places de cotation 00:00:00 29/04/2024			Varia. 5j.	Varia. 1 janv.
15,84 ^CNY	-0,25 %		+3,94 %	+8,20 %

22/04	Cisen Pharmaceutical Co. publie ses résultats pour le premier trimestre clos le 31 mars 2024	CI
2023	Cisen Pharmaceutical abandonne son projet de scission d'unités	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Cisen Pharmaceutical Names Chief Financial Officer	23/04
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	22/04
Cisen Pharmaceutical Scraps Unit Spin-Off Plan	01/12
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23
Cisen Pharmaceutical Co., Ltd.(XSSC:603367) added to S&P Global BMI Index	18/09/23
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24/08/23
Cisen Pharmaceutical to Spin Off Unit for Shenzhen Float	09/06/23
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/04/23
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	30/03/23
Cisen Pharmaceutical Secures Regulatory Approval for Methylcobalamin Tablets	22/11/22
Cisen Pharmaceutical Gets Regulatory Approval for Registration of Two Drugs	17/11/22
Cisen Pharma Gets Regulatory Nod For Flu Drug's China Clinical Trial	09/11/22
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	17/10/22
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22/08/22
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	26/04/22
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	25/03/22
Shijiazhuang No.4 Pharmaceutical Co., Ltd. completed the acquisition of 6.1% stake in Cisen Pharmaceutical Co., Ltd. from Wu Hengke.	31/12/21
Cisen Pharmaceutical Co., Ltd.(XSSC:603367) dropped from S&P Global BMI Index	20/12/21
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	26/10/21
Sichuan Kelun Pharmaceutical Co., Ltd. completed the acquisition of 10% stake in Cisen Pharmaceutical Co., Ltd. from Tianjin Qianding Enterprise Management Partnership (Limited Partnership).	14/09/21

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Cisen Pharmaceutical Co., Ltd.

Actions

603367

CNE100002VG4

Autres langues

Filtres